• Explore /
  • Poster
  • / Glycoprotein D, a checkpoint inhibitor of early T-cell activation, to improve immunogenicity and efficacy of an HPV-16 vaccine in preclinical studies.

Glycoprotein D, a checkpoint inhibitor of early T-cell activation, to improve immunogenicity and efficacy of an HPV-16 vaccine in preclinical studies.

Abstract Poster

Authors

null

Hildegund Ertl

The Wistar Institute, Philadelphia, PA

Hildegund Ertl, Zhiquan Xiang, Yan Li, Andrew Luber, Colin Magowan, Xiang Zhou

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Immune Checkpoints and Stimulatory Receptors

Citation

J Clin Oncol 38, 2020 (suppl 5; abstr 71)

Abstract #

71

Poster Bd #

D4

Abstract Disclosures

Similar Posters

First Author: Michael Bitzer

First Author: Bailey Fabiny Garb

First Author: Christophe Le Tourneau

First Author: Ryan J. Sullivan